You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 9,086,580


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,086,580
Title:Contact lens use in the treatment of an ophthalmologic condition
Abstract: The disclosure relates to the use of contact lenses for treating ophthalmologic conditions, such as presbyopia, induced myopia, computer vision syndrome, insufficient accommodation, or a condition associated with insufficient accommodation. The contact lens may be selected based on a measured sagittal depth and/or eccentricity of the cornea. When fitted, fluid may accumulate between the cornea of the eye and the contact lens. The lens may exhibit a sufficient amount of apical clearance such that when the wearer blinks, the lens moves no more than 1 mm on the eye. The lens may be structured such that bubbles greater than 0.5 mm in diameter are prevented from forming between the contact lens and the eye. The contact lens may be used in combination with a suitable bioactive agent providing for enhanced visual correction.
Inventor(s): Grant; Stuart C. (Los Angeles, CA), Osio Hernandez-Pons; Alberto (Mexico City, MX), Rinehart; John Michael (Peoria, AZ)
Assignee: Osio Corporation (Coronado, CA)
Application Number:13/963,992
Patent Claims:1. A method of fitting a contact lens for an eye of a subject, comprising: measuring a radius of curvature at the flattest corneal meridian of the eye; selecting a contact lens having an optic zone with a curvature that varies from a curvature at the flattest corneal meridian of the eye by between 2.0 and 6.0 diopters; and determining a sagittal depth of the cornea of the eye and selecting a contact lens having an optic zone with a radius of curvature equal to the sagittal depth of the cornea plus a distance of between 0.05 mm and 0.25 mm.

2. The method of claim 1, wherein selecting the contact lens comprises selecting a contact lens having an optic zone with a curvature that is greater than a curvature at the flattest corneal meridian of the eye by between 2.0 and 6.0 diopters.

3. The method of claim 1, wherein selecting the contact lens comprises selecting a contact lens having an optic zone with a curvature that is less than a curvature at the flattest corneal meridian of the eye by between 2.0 and 6.0 diopters.

4. The method of claim 1, wherein selecting a contact lens comprises selecting a contact lens having an optic zone with a curvature that varies from a curvature at the flattest corneal meridian of the eye by between 3.5 and 5.5 diopters.

5. The method of claim 1, wherein selecting a contact lens comprises selecting a contact lens such that, when the contact lens is fit on to the eye, a fluid volume between the cornea of the eye and the contact lens is maintained between 0.05 cubic mm and 0.3 cubic mm.

6. The method of claim 1, wherein selecting a contact lens comprises selecting a contact lens such that, when the contact lens is fit on to the eye, upon blinking of the eye, the contact lens does not move by more than 1 mm.

7. The method of claim 1, wherein selecting a contact lens comprises selecting a contact lens such that, when the contact lens is fit on to the eye, bubbles greater than 0.5 mm in diameter are prevented from forming between the contact lens and the eye.

8. The method of claim 1, wherein measuring the radius of curvature at the flattest corneal meridian of the eye includes using a keratometer to measure the radius of curvature.

9. A method of fitting a contact lens for an eye of a subject, comprising: measuring a radius of curvature at the flattest corneal meridian of the eye; and selecting a contact lens having an optic zone with a curvature that varies from a curvature at the flattest corneal meridian of the eye by between 2.0 and 6.0 diopters and such that, when the contact lens is fit on to the eye, a fluid volume between the cornea of the eye and the contact lens is maintained between 0.05 cubic mm and 0.3 cubic mm.

10. The method of claim 9, wherein the fluid volume between the cornea of the eye and the contact lens is a tear volume.

11. The method of claim 9, further comprising determining a sagittal depth of the cornea of the eye and selecting a contact lens having an optic zone with a radius of curvature equal to the sagittal depth of the cornea plus a distance of between 0.05 mm and 0.25 mm.

12. The method of claim 9, wherein selecting a contact lens comprises selecting a contact lens having an optic zone with a curvature that varies from a curvature at the flattest corneal meridian of the eye by between 3.5 and 5.5 diopters.

13. The method of claim 9, wherein selecting a contact lens comprises selecting a contact lens such that, when the contact lens is fit on to the eye, upon blinking of the eye, the contact lens does not move by more than 1 mm.

14. The method of claim 9, wherein selecting a contact lens comprises selecting a contact lens such that, when the contact lens is fit on to the eye, bubbles greater than 0.5 mm in diameter are prevented from forming between the contact lens and the eye.

15. The method of claim 9, wherein measuring the radius of curvature at the flattest corneal meridian of the eye includes using a keratometer to measure the radius of curvature.

16. A method of using a contact lens, comprising: selecting a contact lens and placing the contact lens on a cornea of an eye such that, when the selected contact lens is fit on to the eye, a fluid volume between the cornea of the eye and the contact lens is maintained between 0.05 cubic mm and 0.3 cubic mm, the contact lens comprising: an optic zone having an optic zone diameter of between 7.0 mm and 9.0 mm and a radius of curvature of between 7.0 mm and 10.0 mm, wherein the optic zone of the contact lens has a radius of curvature equal to a sagittal depth of the cornea of the eye plus a distance of between 0.05 mm and 0.25 mm, and an inner peripheral region surrounding the optic zone, wherein inner peripheral region has a radius of curvature of between 0.5 mm and 1.5 mm greater than a radius of curvature of the optic zone.

17. A method for treating an ophthalmologic condition, the method comprising: placing a contact lens on a cornea of an eye such that, when the contact lens is fit on to the eye, a fluid volume between the cornea of the eye and the contact lens is maintained between 0.05 cubic mm and 0.3 cubic mm, the contact lens comprising: an optic zone having an optic zone diameter of between 7.0 mm and 9.0 mm and a radius of curvature of between 7.0 mm and 10.0 mm, wherein the optic zone of the contact lens has a radius of curvature equal to a sagittal depth of the cornea of the eye plus a distance of between 0.05 mm and 0.25 mm, and an inner peripheral region surrounding the optic zone, wherein inner peripheral region has a radius of curvature of between 0.5 mm and 1.5 mm greater than a radius of curvature of the optic zone; and applying one or more corneal softening agents to the eye of a subject suffering from or likely to suffer from the ophthalmologic condition.

18. The method of claim 17, wherein the condition is presbyopia, computer vision syndrome (CVS), or insufficient accommodation.

19. The method of claim 17, wherein the one or more corneal softening agents is selected from the group consisting of hyaluronidase, chondroitinase ABC, chondroitinase AC, endo B-galactosidase (keratanase), stromelysin (MM3), bacterial collagenase, interstitial collagenase (MM1), and gelatinase (MM2).

20. The method of claim 19, wherein the method comprises applying hyaluronidase and bacterial collagenase to the eye.

21. The method of claim 20 further comprising applying 1 to 10 USP units per mL hyaluronidase and 5 to 15 USP units per mL bacterial collagenase to the eye.

Details for Patent 9,086,580

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 05/05/2004 ⤷  Try a Trial 2032-08-10
Bausch & Lomb Incorporated VITRASE hyaluronidase Injection 021640 12/02/2004 ⤷  Try a Trial 2032-08-10
Amphastar Pharmaceuticals, Inc. AMPHADASE hyaluronidase Injection 021665 10/26/2004 ⤷  Try a Trial 2032-08-10
Akorn, Inc. HYDASE hyaluronidase Injection 021716 10/25/2005 ⤷  Try a Trial 2032-08-10
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.